Eli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugs

June 17 (UPI) --Eli Lilly and Company said Tuesday it will buy out Boston-based Verve Therapeutics Inc. in a billion dollar deal with plans to advance Verve's new line of experimental cardiac health drugs.
Indianapolis-based Eli Lilly announced its definitive agreement to acquire Verge, a gene-editing startup, for up to $1.3 billion at $10.50 a share -- a premium of 67.5% at last closing -- with the goal to boost Verve's budding pipeline of medicine designed to target and treat a wide-range of cardiovascular-related health issues.
"Lilly is eager to welcome our Verve colleagues to Lilly and continue the development of these promising potential new medicines aimed at improving outcomes for patients with cardiovascular disease and addressing the significant unmet medical need in this space," said Ruth Gimeno, Lilly's group VP for diabetes and metabolic research and development.
Under the agreement terms, the transaction will not be subject to any financing conditions and will include a nearly $1 billion upfront payout plus a further $300 million based on certain clinical milestones.
The deal is expected to close by this year's third quarter subject to conditions.
Verve's medical treatment program, according to a Gimeno, could "shift the treatment paradigm for cardiovascular disease from chronic care to one-and-done treatment."
Meanwhile, stock shares in Verve jumped 76% to over $11 in premarket trading Tuesday morning while Lilly stock value fell 1%.
A years-long study from 2010-2022 released in November revealed how the number of dead via cardiovascular disease had surged among adults ages 25 to 64 living in rural areas.
Verve uses a next gen type of gene editing which erases and rewrites a specific gene letter.
Lilly's Gimeno says the Verve-102 program, which is currently in its Phase 1b clinal trial study and fast-tracked for FDA approval, "has the potential" to be the first "in vivo" gene editing therapy deployed to treat a broad population of patients seeking treatment for cardiac issues.
102 may be utilized for patients seeking treatment for heterozygous familial hypercholesterolemia (HeFH), which is a subset of ASCVD affecting 1 in 250 people.
On Tuesday, Verve's chief noted how in just seven years that the Verve team had progressed three in vivo gene editing products with two currently in clinics.
"Verve was founded with one mission in mind: transform the treatment of cardiovascular disease from chronic care to a one-dose future," said Verve Therapeutics co-founder and CEO Dr. Sekar Kathiresan.
Copyright 2025 UPI News Corporation. All Rights Reserved.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Yahoo

2 hours ago

• Yahoo

Celtics Predicted to Make Trade With Utah Jazz Before NBA Draft

Celtics Predicted to Make Trade With Utah Jazz Before NBA Draft originally appeared on Athlon Sports. The Boston Celtics are in a pickle this offseason. They want to avoid the NBA's second tax apron while remaining a title contender. That will mean some players will have to go to make it work. Advertisement It is a shame because Brad Stevens cleverly constructed a title team, but in the modern NBA, maintaining a title status has become more complicated than ever. The NBA's tax aprons force teams to pull the plug on their teams sooner than they would in the past. Jrue Holiday and Kristaps Porzingis have been the trade candidates that have come up the most. Both played a massive role in the franchise winning its 18th title in 2024. However, even if Boston trades both, they may not be the only ones who get the axe. Boston Celtics president of basketball operations Brad Stevens.© Winslow Townson-Imagn Images Another candidate is Sam Hauser, who will enter the first year of a four-year, $45 million contract next season. PhillyVoice's Adam Aaronson proposed a deal in which the Celtics would trade Hauser and the No. 32 pick in the 2025 NBA Draft to the Utah Jazz for the No. 21 pick. He explained why both sides would agree to a deal. Advertisement "Boston needs to trade Hauser this summer as part of their cost-cutting measures despite his elite three-point shooting and valuable contract," Aaronson wrote. "...The Jazz seem to be looking to improve after posting the worst record in the NBA last season, and dropping 11 spots in this range to add a shooter of Hauser's caliber on such a team-friendly deal is an obvious win." Stevens would make a trade with his front office predecessor, Danny Ainge. While that connection could make a trade more likely, Stevens has gotten in the way of the Jazz's offseason plans before, as they wanted Porzingis and Holiday two years ago before the Celtics got them. That could factor into whether Utah wants to deal with Boston. Related: NFL Star Lamar Jackson Sends 5-Word Message to Jayson Tatum Related: TJ McConnell Receives Message From Ex-Celtics Star Before NBA Finals Game 7 This story was originally reported by Athlon Sports on Jun 20, 2025, where it first appeared.

2 hours ago

Conservation group makes $60M land deal to end mining threat outside Okefenokee Swamp

SAVANNAH, Ga. -- A conservation group said Friday it has reached a $60 million deal to buy land outside the Okefenokee Swamp from a mining company that environmentalists spent years battling over a proposed mine that opponents feared could irreparably damage an ecological treasure. The Conservation Fund said it will buy all 7,700 acres (31.16 square kilometers) that Alabama-based Twin Pines Minerals owns outside the Okefenokee National Wildlife Refuge in southeast Georgia, halting the company's mining plans. 'It's a big undertaking, but it was also an existential threat to the entire refuge," said Stacy Funderburke, the Conservation Fund's vice president for the central Southeast. 'We've done larger deals for larger acres, but dollar-wise this is the largest deal we've ever done in Georgia." Twin Pines President Steven Ingle confirmed the sale through a spokesman, but declined to comment further. Twin Pines of Birmingham, Alabama, had worked since 2019 to obtain permits to mine titanium dioxide, a pigment used to whiten products from paint to toothpaste, less than 3 miles (5 kilometers) from the southeastern boundary of the Okefenokee refuge near the Georgia-Florida line. The Okefenokee is the largest U.S. refuge east of the Mississippi River, covering nearly 630 square miles (1,630 square kilometers) in southeast Georgia. It is home to abundant alligators, stilt-legged wood storks and more than 400 other animal species. The mine appeared to be on the cusp of winning final approval early last year. Georgia regulators issued draft permits in February 2024 despite warnings from scientists that mining near the Okefenokee's bowl-like rim could damage its ability to hold water and increase the frequency of withering droughts. Twin Pines insisted it could mine without damaging the swamp. Regulators with the Georgia Environmental Protection Division agreed, concluding last year that mining should have a 'minimal impact' on the refuge. The decisions by Georgia regulators played an outsize role in the Twin Pines project after environmental rollbacks during President Donald Trump's first term stripped the federal government of any oversight. Advocates battling Twin Pines said there is still a potential threat to the Okefenokee, with thousands of acres of privately owned land remaining unprotected. Georgia lawmakers have batted aside multiple attempts in recent years to prohibit mining near the refuge. 'There's maybe 30,000 acres that's still vulnerable outside the Okefenokee on Trail Ridge that needs to be conserved,' said Rena Ann Peck of the Georgia River Network. Josh Marks, an Atlanta environmental attorney who fought the mining project, called the land sale 'a huge victory.' But he also called on conservationists to redouble efforts for a state law protecting the Okefenokee and to keep pressure on other companies to refrain from mining near the refuge. Funderburke said the steep purchase price for Twin Pines' land was driven largely by its mineral-rich soils that would have been highly valued by other mining operations. Reaching a deal became more urgent with the company so close to obtaining its final permits. 'It became pretty clear once a draft permit was issued last year that this was the final exit ramp' to stopping the project, Funderburke said. He said his group was closing Friday on about 40% of the property that includes the 820-acre (332-hectare) site for which Twin Pines' had sought its mining permit. The Conservation Fund plans to close on the rest by the end of July. Funderburke said he hopes there is eventually a deal for the land to pass into government ownership and protection. The U.S. Fish and Wildlife Service, which oversees the Okefenokee refuge, in January approved a plan to expand the refuge by buying up to 22,000 acres (8,900) along its perimeter from private owners. The proposal included land owned by Twin Pines. Negotiations with the Conservation Fund might explain why Twin Pines had yet to follow through on a financial commitment required before Georgia regulators could make a final decision on its mining permit. The Environmental Protection Division recently confirmed Twin Pines had been notified in February 2024 that it needed to set aside $2 million for future restoration of the mining site. The company never followed through in the 16 months before the sale was announced.

Business Insider

4 hours ago

• Business Insider

Walmart (WMT) Pays $10 Million Fine to Settle Lawsuit over Money Transfer Fraud

Walmart (WMT) has agreed to pay a $10 million fine to settle a U.S. Federal Trade Commission civil lawsuit accusing the world's largest retailer of ignoring warning signs that scam artists leveraged its money transfer service to bilk consumers out of hundreds of millions of dollars. Confident Investing Starts Here: Walmart has also agreed not to process money transfers it suspects are fraudulent, or help sellers and telemarketers it believes are using its services to commit fraud. 'Electronic money transfers are one of the most common ways that scammers tell consumers to send them money, because once it's sent, it's gone for good,' said Christopher Mufarrige, director of the FTC Consumer Protection Bureau. Bentonville, Arkansas-based Walmart did not admit or deny wrongdoing in settling the case. In its complaint, the FTC accused Walmart of turning a blind eye to fraudsters who used its money transfer service to target consumers. Walmart acts as an agent for money transfers by companies such as MoneyGram and Western Union (WU). Tricksters The FTC said fraudsters used many schemes via Walmart, including impersonating Internal Revenue Service (IRS) agents, impersonating family members, and telling victims they won lotteries or sweepstakes but owed fees to collect their winnings. The judge dismissed part of the FTC's legal claim last year but let the regulator pursue most of its case. Walmart appealed that decision. The $10 million settlement effectively ends Walmart's appeal. WMT stock is up 6% this year. Is WMT Stock a Buy? average WMT price target of $109.71 implies 14.14% upside from current levels.